What Is a GLP-1? Your Complete Guide to GLP-1 Hormones and Medications

What Is a GLP-1? Your Complete Guide to GLP-1 Hormones and Medications

By Dr. Onikepe Adegbola, MD PhD

GLP-1 stands for glucagon-like peptide-1. It's a hormone your body produces naturally in the small intestine after you eat. It tells your pancreas to release insulin, tells your brain you're full, and slows the speed at which food leaves your stomach. Simple enough in concept. The clinical reality of what GLP-1 does, why it matters, and how medications that mimic it are changing metabolic medicine is considerably more interesting.

As a physician who specializes in GLP-1 therapy at Mochi Health, I explain this hormone to patients daily. If you've been asking "what is a GLP-1?" after hearing about Ozempic or Wegovy, this article is the version of that conversation I'd have if we had an hour instead of fifteen minutes.

Key Takeaways

• GLP-1 is a naturally occurring incretin hormone produced by L-cells in the small intestine
• It regulates blood sugar through insulin secretion, glucagon suppression, and gastric emptying
• GLP-1 also acts on the brain's appetite centers, producing satiety signals
• GLP-1 receptor agonist medications (semaglutide, tirzepatide) mimic and amplify this natural hormone's effects
• Research continues to reveal GLP-1's roles beyond metabolism, including cardiovascular protection and potential neuroprotection

GLP-1: The Biology Behind the Buzzword

Your body runs on a communication network between your gut, pancreas, and brain. GLP-1 is one of the key messengers in that network. It belongs to a class of hormones called incretins, which are released from the intestinal lining in response to food.

When you eat a meal, specialized cells called L-cells in your small intestine and colon detect nutrients (particularly glucose and fatty acids) and release GLP-1 into the bloodstream. This sets off a cascade of effects:

Effect 1: Insulin Release (Glucose-Dependent)

GLP-1 binds to receptors on pancreatic beta cells and stimulates insulin secretion. The critical detail: this happens only when blood glucose is elevated. When blood sugar drops to normal levels, the insulin-stimulating effect turns off. This glucose-dependent mechanism is why GLP-1-based therapies have a lower risk of hypoglycemia compared to older diabetes medications like sulfonylureas, which push insulin release regardless of glucose levels.

Effect 2: Glucagon Suppression

While stimulating insulin, GLP-1 simultaneously suppresses glucagon secretion from pancreatic alpha cells. Glucagon raises blood sugar by telling the liver to release stored glucose. By turning down glucagon when blood sugar is already adequate, GLP-1 prevents the liver from dumping extra glucose you don't need.

Effect 3: Slowed Gastric Emptying

GLP-1 slows the rate at which food moves from your stomach into your small intestine. This means glucose from meals enters the bloodstream more gradually, preventing the sharp post-meal blood sugar spikes that drive insulin resistance over time. It also contributes to feeling full longer after eating.

Effect 4: Central Appetite Regulation

GLP-1 receptors exist throughout the brain, with high concentrations in the hypothalamus (the hunger control center) and the brainstem. When GLP-1 activates these receptors, it produces satiety signals that reduce appetite, decrease food reward signaling, and help regulate food-seeking behavior.

This is the effect that made GLP-1 medications famous for weight loss. The caloric reduction patients experience on these medications isn't willpower. It's neurochemistry. The brain's hunger signals are genuinely quieter.

The Natural GLP-1 Problem

Here's why understanding what a GLP-1 is matters for understanding the medications. Natural GLP-1 has a half-life of about 2-3 minutes. An enzyme called DPP-4 breaks it down almost immediately after release. Your body produces GLP-1 in bursts after meals, and it's gone before you'd have time to measure it in most lab settings.

In people with type 2 diabetes and obesity, GLP-1 secretion is often reduced. The incretin effect (the amplification of insulin release caused by oral nutrient intake compared to IV glucose) is blunted. You eat, but the hormonal cascade that should regulate your blood sugar and appetite is weaker than it should be.

This is the biological rationale for GLP-1 receptor agonist medications: replace what's deficient or amplify what's insufficient.

From Natural Hormone to Medication: How GLP-1 Drugs Work

GLP-1 receptor agonist medications are synthetic versions of GLP-1 that have been engineered to resist DPP-4 degradation. Instead of lasting minutes, they persist in the bloodstream for days or weeks.

The major GLP-1 receptor agonists currently available:

• Semaglutide (Ozempic, Wegovy, Rybelsus): Weekly injectable or daily oral. The most widely used GLP-1 RA for both diabetes and obesity.
• Tirzepatide (Mounjaro, Zepbound): A dual GIP/GLP-1 receptor agonist. Activates both incretin pathways simultaneously, producing somewhat greater weight loss in head-to-head comparisons.
• Liraglutide (Victoza, Saxenda): Daily injectable. The first GLP-1 RA approved for chronic weight management.
• Dulaglutide (Trulicity): Weekly injectable for type 2 diabetes.
• Exenatide (Byetta, Bydureon): Twice-daily or weekly injectable. The first GLP-1 RA ever approved.

Each of these medications binds to the same GLP-1 receptor that natural GLP-1 activates. The difference is duration and potency. Where your natural GLP-1 whispers for two minutes after a meal, semaglutide effectively shouts for seven days straight.

What GLP-1 Does Beyond Blood Sugar and Weight

The research on GLP-1's effects has expanded dramatically. GLP-1 receptors appear in tissues far beyond the pancreas and brain, suggesting this hormone plays broader physiological roles than initially understood.

Cardiovascular Protection

The SELECT trial demonstrated that semaglutide reduces major adverse cardiovascular events by 20% in patients with obesity and established cardiovascular disease. This wasn't primarily a glucose-lowering effect. Patients without diabetes saw similar cardiovascular benefit. The mechanisms likely involve reduced inflammation, improved endothelial function, and direct effects on cardiac tissue where GLP-1 receptors are present.

Liver Health

Semaglutide has shown significant benefit in metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH). In clinical trials, semaglutide resolved steatohepatitis in 59% of patients compared to 17% with placebo. GLP-1 receptor activation appears to reduce hepatic fat accumulation and inflammation through direct and indirect pathways.

Kidney Protection

The FLOW trial demonstrated that semaglutide reduced the progression of chronic kidney disease in patients with type 2 diabetes. This renal protective effect adds to the growing evidence that GLP-1 receptor agonists benefit multiple organ systems simultaneously.

Potential Neurological Effects

GLP-1 receptors in the brain aren't limited to appetite regulation. Preclinical and early clinical data suggest neuroprotective properties, with studies investigating GLP-1 receptor agonists in Alzheimer's disease and Parkinson's disease. This research is early stage but intriguing.

Living with GLP-1 Therapy: What Patients Need to Know

Understanding what a GLP-1 is helps contextualize the experience of taking these medications. The side effects make more biological sense when you understand the mechanism.

Nausea, the most common side effect? That's gastric emptying slowing down. Your stomach is holding food longer than it used to. Reduced appetite? That's the hypothalamic effect. Constipation? Also related to slowed GI motility.

These effects are features of the mechanism, not bugs. But they require management. Patients who understand the biology tend to manage better because they can anticipate and adapt.

Nutritional support during GLP-1 therapy deserves particular attention. When appetite drops and food intake decreases, nutrient density per calorie becomes critical. Protein needs remain high (to preserve muscle mass during weight loss), vitamin and mineral requirements don't decrease, and the GI tract needs support to handle altered motility.

Casa de Sante GLP-1 supplements address these specific challenges with formulations designed for patients on GLP-1 medications. From digestive enzyme support to protein supplementation to targeted multivitamins, these gut-gentle products fill the nutritional gaps that reduced food intake creates.

The Future of GLP-1 Science

The GLP-1 field is moving fast. Next-generation medications in development include triple agonists (GLP-1/GIP/glucagon receptor), oral semaglutide at higher doses for weight management, and combination therapies targeting multiple metabolic pathways simultaneously.

When someone asks "what is a GLP-1," the answer used to be simple: a gut hormone that regulates blood sugar. The conversation has since expanded to "what can GLP-1 receptor activation do across the entire body?" The answer, based on emerging data, is substantially more than we expected even five years ago.

For patients and for physicians, this is a category of medicine that rewards staying informed. The evidence base is growing monthly. What we recommend today may be refined by new data next quarter.

Frequently Asked Questions

Is GLP-1 a natural hormone?

Yes. GLP-1 is produced naturally by L-cells in your small intestine and colon in response to eating. Your body makes it after every meal. The natural form has a very short half-life (2-3 minutes) before being broken down by the enzyme DPP-4. GLP-1 receptor agonist medications are engineered versions that last much longer, amplifying the natural hormone's effects.

What's the difference between GLP-1 and a GLP-1 agonist?

GLP-1 is the hormone itself. A GLP-1 agonist (or GLP-1 receptor agonist) is a medication that binds to and activates the same receptor that natural GLP-1 activates. The medication mimics the hormone but is modified to last longer in the body. Think of GLP-1 as the key your body makes naturally, and a GLP-1 agonist as a copy of that key that fits the same lock but doesn't break down as quickly.

Can I increase my natural GLP-1 levels without medication?

Some evidence suggests that certain dietary strategies may modestly increase GLP-1 secretion. High-protein meals, fiber-rich foods, and fermented foods have all been associated with increased incretin release. Moderate exercise also appears to boost GLP-1 levels. However, the magnitude of these natural increases is far less than what GLP-1 receptor agonist medications achieve. Lifestyle strategies are complementary, not equivalent to pharmacotherapy.

Why does GLP-1 cause nausea?

GLP-1 slows gastric emptying, meaning food stays in the stomach longer. This can create a sensation of fullness that crosses into nausea, especially when food volume exceeds what the slower-moving stomach can comfortably handle. GLP-1 also acts on brainstem areas involved in nausea signaling. Gradual dose titration and smaller meal sizes help the body adapt. Most patients find nausea improves within 4-8 weeks at a stable dose.